← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Alight revenue fell 3.0% and a $3.1B goodwill impairment drove a huge loss, but free cash flow rose to $250.0M.
The read at a glance✓ Audited against SEC data
- Business mix — Employer benefits and human-capital servicesNote
- Revenue — Revenue fell 3.0% to $2.26BWatch
- Profitability — Net loss was $3.10BWatch
- Cash — Free cash flow rose 90.8%OK
- Insiders — Cluster buy: 10 buys / 0 sellsOK
- Balance sheet — Equity fell 75.8%Watch
- Accounting — Altman-Z distress; EQ safeWatch
Business
Alight is a technology-enabled services company delivering human capital management solutions, including benefits administration, healthcare navigation, financial wellbeing, leave management, and retiree healthcare.
Where the revenue comes from
Fiscal 2025, as Alight, Inc. / Delaware reports it. History and quarterly detail are in the app.
Leadership changes
From Alight, Inc. / Delaware's own filings, the day they're filed.
- Stephen A. Lasher · Chief Financial Officer · appointmenteff. 2026-06-15
- Gregory Giometti · Chief Financial Officer · departureeff. 2026-02-25
- Jeremy J. Heaton · Chief Financial Officer · departureeff. 2026-01-09
Latest filings
- 10-Q · Quarterly report2026-08-04
- 8-K · Company announcement2026-08-04
- 8-K · Company announcement2026-07-01
- 8-K · Company announcement2026-06-18
- 8-K · Company announcement2026-06-11
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Alight, Inc. / Delaware, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.